Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2013; 19(16): 2543-2549
Published online Apr 28, 2013. doi: 10.3748/wjg.v19.i16.2543
Published online Apr 28, 2013. doi: 10.3748/wjg.v19.i16.2543
Characteristics | Total (n = 412) | Severe hepatitis (n = 92) | Non-severe hepatitis (n = 320) | P value | Prolonged cholestasis(n = 21) | Non-prolonged cholestasis (n = 391) | P value |
Age1 (yr) | 34.4 ± 11.4 | 36.5 ± 11.5 | 33.8 ± 11.4 | 0.035 | 42.6 ± 15.0 | 34.0 ± 11.1 | 0.013 |
Gender, male | 237 (57.5) | 62 (67.4) | 175 (54.7) | 0.032 | 11 (52.4) | 226 (57.8) | 0.655 |
Etiology | |||||||
Hepatitis A | 319 (77.4) | 67 (72.8) | 252 (78.8) | 8 (38.1) | 311 (79.5) | ||
Toxic | 44 (10.7) | 17 (18.5) | 27 (8.4) | 10 (47.6) | 34 (8.7) | ||
Unknown | 25 (6.1) | 1 (1.1) | 24 (7.5) | 0 (0) | 25 (6.4) | ||
Hepatitis B | 16 (3.9) | 4 (4.3) | 12 (3.8) | 2 (9.5) | 14 (3.6) | ||
Alcohol | 4 (1.0) | 1 (1.1) | 3 (0.9) | 0 (0) | 4 (1.0) | ||
Hepatitis C | 2 (0.5) | 1 (1.1) | 1 (0.3) | 1 (4.8) | 1 (0.3) | ||
Autoimmune | 2 (0.5) | 1 (1.1) | 1 (0.3) | 0 (0) | 2 (0.5) | ||
Etiology, toxic | 44 (10.7) | 17 (18.5) | 27 (8.4) | 0.001 | 10 (47.6) | 34 (8.7) | < 0.001 |
ALT1 (IU/L) | 2053 ± 1759 | 2145 ± 2207 | 2027 ± 1611 | 0.392 | 998 ± 1090 | 2110 ± 1772 | 0.001 |
ALP1 (IU/mL) | 155 ± 75 | 152 ± 72 | 156 ± 76 | 0.983 | 153 ± 110 | 156 ± 73 | 0.265 |
Bilirubin1 (mg/dL) | 5.6 ± 4.9 | 11.2 ± 6.7 | 3.9 ± 2.6 | < 0.001 | 18.6 ± 6.9 | 4.9 ± 3.7 | < 0.001 |
Albumin1 (g/dL) | 3.9 ± 0.4 | 3.8 ± 0.4 | 4.0 ± 0.4 | < 0.001 | 3.8 ± 0.4 | 3.9 ± 0.4 | 0.174 |
PT1 (%) | 81.0 ± 18.0 | 75.2 ± 22.7 | 83.7 ± 16.6 | 0.003 | 84.6 ± 15.0 | 81.7 ± 18.6 | 0.721 |
GWT1, mm | 5.2 ± 5.5 | 7.2 ± 6.0 | 5.5 ± 5.3 | 0.009 | 9.6 ± 6.7 | 5.7 ± 5.4 | 0.003 |
> 3 | 233 (56.5) | 70 (70.7) | 168 (51.7) | 0.004 | 17 (81.0) | 216 (55.2) | 0.025 |
> 7 | 142 (34.5) | 36 (39.1) | 106 (33.1) | 0.040 | 11 (52.4) | 131 (33.5) | 0.005 |
Arterial heterogeneity (+) | 294 (80.1) | 68 (73.9) | 226 (70.6) | 0.755 | 15 (71.5) | 279 (71.3) | 1.000 |
Periportal tracking (+) | 348 (84.7) | 78 (84.8) | 270 (84.4) | 0.869 | 18 (85.7) | 330 (84.4) | 1.000 |
LN number1 | 4.8 ± 3.0 | 5.1 ± 3.3 | 4.8 ± 2.9 | 0.581 | 5.3 ± 3.7 | 4.8 ± 3.0 | 0.701 |
LN size1 (cm) | 0.97 ± 0.26 | 0.99 ± 0.28 | 0.96 ± 0.26 | 0.465 | 0.97 ± 0.30 | 0.97 ± 0.26 | 0.743 |
≥ 0.8 | 346 (84.5) | 79 (85.9) | 267 (83.4) | 0.632 | 17 (81.0) | 329 (84.1) | 0.759 |
> 1 | 162 (39.3) | 42 (45.7) | 120 (37.5) | 0.183 | 10 (47.6) | 152 (38.9) | 0.494 |
Ascites (+) | 56 (13.6) | 17 (18.5) | 39 (12.2) | 0.123 | 7 (33.3) | 49 (12.5) | 0.015 |
Spleen size1 (cm) | 10.9 ± 1.6 | 11.04 ± 1.68 | 10.84 ± 1.60 | 0.419 | 10.44 ± 1.7 | 10.91 ± 1.6 | 0.094 |
≥ 12 | 95 (23.1) | 24 (26.1) | 71 (22.2) | 0.483 | 3 (14.3) | 92 (23.5) | 0.431 |
GWT | LN maximum size | LN number | Spleen size | Arterial heterogeneity | Periportal tracking | Ascites | |||||||
Absence (n = 73) | Presence (n = 294) | P value | Absence (n = 63) | Presence (n = 348) | P value | Absence (n = 356) | Presence (n = 56) | P value | |||||
ALT(IU/L) | 0.234 (< 0.001) | 0.164 (0.001) | -0.013 (0.798) | 0.119 (0.015) | 1504 ± 1478 | 2216 ± 1794 | < 0.001 | 1994 ± 2139 | 2064 ± 1688 | 0.074 | 1981 ± 1769 | 2509 ± 1641 | 0.005 |
ALP (IU/mL) | 0.180 (< 0.001) | 0.135 (0.006) | 0.150 (0.003) | 0.086 (0.082) | 145 ± 76 | 159 ± 75 | 0.108 | 133 ± 63 | 159 ± 76 | 0.007 | 154 ± 76 | 164 ± 66 | 0.152 |
Bilirubin (mg/dL) | 0.319 (< 0.001) | 0.138 (0.005) | 0.202 (< 0.001) | 0.190 (< 0.001) | 5.6 ± 5.2 | 5.6 ± 4.9 | 0.451 | 4.3 ± 5.1 | 5.8 ± 4.9 | < 0.001 | 5.3 ± 4.7 | 7.0 ± 5.9 | 0.012 |
PT (s) | -0.118 (0.017) | -0.038 (0.445) | 0.072 (0.149) | -0.092 (0.061) | 86 ± 16 | 81 ± 18 | 0.032 | 81 ± 20 | 82 ± 18 | 0.795 | 82 ± 18 | 76 ± 17 | 0.006 |
Albumin (g/dL) | -0.282 (< 0.001) | -0.018 (0.717) | -0.017 (0.739) | -0.062 (0.206) | 4.0 ± 0.4 | 3.9 ± 0.4 | 0.404 | 4.1 ± 0.4 | 3.9 ± 0.4 | 0.002 | 4.0 ± 0.4 | 3.7 ± 0.4 | < 0.001 |
Variables | OR | 95%CI for OR | P value | |
Lower | Upper | |||
Severe acute hepatitis | ||||
Age (yr) | 1.007 | 0.928 | 1.033 | 0.579 |
Gender, male | 2.569 | 1.477 | 4.469 | 0.001 |
Etiology, toxic | 3.531 | 1.444 | 8.635 | 0.006 |
Albumin (g/dL) | 2.154 | 1.279 | 3.629 | 0.004 |
GWT (mm) | 1.061 | 1.015 | 1.110 | 0.009 |
Prolonged cholestasis in acute hepatitis | ||||
Age (yr) | 0.393 | 0.059 | 2.599 | 0.333 |
Etiology, toxic | 6.848 | 0.960 | 48.859 | 0.055 |
ALT (IU/L) | 1.000 | 1.000 | 1.001 | 0.607 |
Bilirubin (mg/dL) | 1.628 | 1.331 | 1.991 | < 0.001 |
GWT (mm) | 1.172 | 1.024 | 1.342 | 0.021 |
Ascites | 0.484 | 0.119 | 6.039 | 0.869 |
- Citation: Park SJ, Kim JD, Seo YS, Park BJ, Kim MJ, Um SH, Kim CH, Yim HJ, Baik SK, Jung JY, Keum B, Jeen YT, Lee HS, Chun HJ, Kim CD, Ryu HS. Computed tomography findings for predicting severe acute hepatitis with prolonged cholestasis. World J Gastroenterol 2013; 19(16): 2543-2549
- URL: https://www.wjgnet.com/1007-9327/full/v19/i16/2543.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i16.2543